Cargando…
Safety and effectiveness of all-oral and injectable-containing, bedaquiline-based long treatment regimen for pre-XDR tuberculosis in Vietnam
Background: The World health organization (WHO) recently recommended standardized all-oral shorter regimens for rifampicin resistant Tuberculosis (RR-TB). For highly resistant Tuberculosis patients such as pre-XDR-TB: RR-TB plus additional resistance to fluoroquinolones (FQ), the 6–9-months bedaquil...
Autores principales: | Nguyen, Thi Mai Phuong, Nguyen, Binh Hoa, Hoang, Thi Thanh Thuy, Nguyen, Hoang Anh, Vu, Dinh Hoa, Nguyen, Mai Hoa, Nguyen, Bao Ngoc, Decroo, Tom, Nguyen, Viet Nhung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614239/ https://www.ncbi.nlm.nih.gov/pubmed/36313324 http://dx.doi.org/10.3389/fphar.2022.1023704 |
Ejemplares similares
-
Effectiveness and safety of bedaquiline-based, modified all-oral 9–11-month treatment regimen for rifampicin-resistant tuberculosis in Vietnam
por: Nguyen, Thi Mai Phuong, et al.
Publicado: (2023) -
Active surveillance for adverse events in patients on longer treatment regimens for multidrug-resistant tuberculosis in Viet Nam
por: Ngoc, Nguyen Bao, et al.
Publicado: (2021) -
Challenges in detection and treatment of multidrug resistant tuberculosis patients in Vietnam
por: Hoang, Thuy Thi Thanh, et al.
Publicado: (2015) -
Predictors of treatment outcomes among patients with multidrug-resistant tuberculosis in Vietnam: a retrospective cohort study
por: Wrohan, Ian, et al.
Publicado: (2022) -
Mutation spectrum of ATP7B gene in pediatric patients with Wilson disease in Vietnam
por: Huong, Nguyen Thi Mai, et al.
Publicado: (2022)